87 related articles for article (PubMed ID: 7842297)
21. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
[TBL] [Abstract][Full Text] [Related]
22. Quantitative study of neurofibrillary tangles in subdivisions of the hippocampus. CA2 as a special area in normal aging and senile dementia of the Alzheimer type.
Mizutani T; Shimada H
Acta Pathol Jpn; 1991 Aug; 41(8):597-603. PubMed ID: 1750357
[TBL] [Abstract][Full Text] [Related]
23. Alzheimer-related tau-pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia.
Thal DR; Holzer M; Rüb U; Waldmann G; Günzel S; Zedlick D; Schober R
Exp Neurol; 2000 May; 163(1):98-110. PubMed ID: 10785448
[TBL] [Abstract][Full Text] [Related]
24. CA1 hippocampal neuronal loss in familial Alzheimer's disease presenilin-1 E280A mutation is related to epilepsy.
Velez-Pardo C; Arellano JI; Cardona-Gomez P; Jimenez Del Rio M; Lopera F; De Felipe J
Epilepsia; 2004 Jul; 45(7):751-6. PubMed ID: 15230697
[TBL] [Abstract][Full Text] [Related]
25. Altered expression of COX-2 in subdivisions of the hippocampus during aging and in Alzheimer's disease: the Hisayama Study.
Fujimi K; Noda K; Sasaki K; Wakisaka Y; Tanizaki Y; Iida M; Kiyohara Y; Kanba S; Iwaki T
Dement Geriatr Cogn Disord; 2007; 23(6):423-31. PubMed ID: 17457030
[TBL] [Abstract][Full Text] [Related]
26. Hippocampal shape analysis in Alzheimer's disease: a population-based study.
Scher AI; Xu Y; Korf ES; White LR; Scheltens P; Toga AW; Thompson PM; Hartley SW; Witter MP; Valentino DJ; Launer LJ
Neuroimage; 2007 May; 36(1):8-18. PubMed ID: 17434756
[TBL] [Abstract][Full Text] [Related]
27. Distribution, morphological features, and synaptic connections of parvalbumin- and calbindin D28k-immunoreactive neurons in the human hippocampal formation.
Seress L; Gulyás AI; Ferrer I; Tunon T; Soriano E; Freund TF
J Comp Neurol; 1993 Nov; 337(2):208-30. PubMed ID: 8276998
[TBL] [Abstract][Full Text] [Related]
28. The neuropathological changes associated with normal brain aging.
Hof PR; Glannakopoulos P; Bouras C
Histol Histopathol; 1996 Oct; 11(4):1075-88. PubMed ID: 8930649
[TBL] [Abstract][Full Text] [Related]
29. Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation.
Kril JJ; Patel S; Harding AJ; Halliday GM
Acta Neuropathol; 2002 Apr; 103(4):370-6. PubMed ID: 11904757
[TBL] [Abstract][Full Text] [Related]
30. Distribution of parvalbumin-immunoreactive cells and fibers in the monkey temporal lobe: the hippocampal formation.
Pitkänen A; Amaral DG
J Comp Neurol; 1993 May; 331(1):37-74. PubMed ID: 8320348
[TBL] [Abstract][Full Text] [Related]
31. Reversal of amyloid beta toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid beta antibody.
Chauhan NB; Siegel GJ
J Neurosci Res; 2002 Jul; 69(1):10-23. PubMed ID: 12111811
[TBL] [Abstract][Full Text] [Related]
32. The spatial patterns of Lewy bodies, senile plaques, and neurofibrillary tangles in dementia with Lewy bodies.
Armstrong RA; Cairns NJ; Lantos PL
Exp Neurol; 1998 Mar; 150(1):122-7. PubMed ID: 9514834
[TBL] [Abstract][Full Text] [Related]
33. Severe cardiovascular disease and Alzheimer's disease: senile plaque formation in cortical areas.
Soneira CF; Scott TM
Clin Anat; 1996; 9(2):118-27. PubMed ID: 8720786
[TBL] [Abstract][Full Text] [Related]
34. Functional alterations in Alzheimer's disease: diminution of cytochrome oxidase in the hippocampal formation.
Simonian NA; Hyman BT
J Neuropathol Exp Neurol; 1993 Nov; 52(6):580-5. PubMed ID: 8229076
[TBL] [Abstract][Full Text] [Related]
35. Transferrin receptors in the normal human hippocampus and in Alzheimer's disease.
Morris CM; Candy JM; Kerwin JM; Edwardson JA
Neuropathol Appl Neurobiol; 1994 Oct; 20(5):473-7. PubMed ID: 7845533
[TBL] [Abstract][Full Text] [Related]
36. Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer's disease detected in vivo with magnetic resonance imaging.
Raven EP; Lu PH; Tishler TA; Heydari P; Bartzokis G
J Alzheimers Dis; 2013; 37(1):127-36. PubMed ID: 23792695
[TBL] [Abstract][Full Text] [Related]
37. An immunohistochemical study of the serotonin 1A receptor in the hippocampus of subjects with Alzheimer's disease.
Mizukami K; Ishikawa M; Akatsu H; Abrahamson EE; Ikonomovic MD; Asada T
Neuropathology; 2011 Oct; 31(5):503-9. PubMed ID: 21269332
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical Analysis of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) Expression in the Rat and Human Hippocampus: Decline in CA3 During Progression of Alzheimer's Disease.
Adams SL; Benayoun L; Tilton K; Mellott TJ; Seshadri S; Blusztajn JK; Delalle I
J Alzheimers Dis; 2018; 63(4):1433-1443. PubMed ID: 29843236
[TBL] [Abstract][Full Text] [Related]
39. c-fos protein-like immunoreactivity: distribution in the human brain and over-expression in the hippocampus of patients with Alzheimer's disease.
Zhang P; Hirsch EC; Damier P; Duyckaerts C; Javoy-Agid F
Neuroscience; 1992; 46(1):9-21. PubMed ID: 1594107
[TBL] [Abstract][Full Text] [Related]
40. Quantitative analysis of lipofuscin and neurofibrillary tangles in the hippocampal neurons of Alzheimer disease brains.
Stojanovic A; Roher AE; Ball MJ
Dementia; 1994; 5(5):229-33. PubMed ID: 7951677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
